# China-Belgium Direct Equity Investment Fund

> China-Belgium Direct Equity Investment Fund is a VC fund backing Semiconductor and Manufacturing. See 6 investments, round sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 6
- Last investment: Feb 2023
- Lead investor: 17%
- Last updated: Aug 2026

China-Belgium Direct Equity Investment Fund is an investment firm.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Semiconductor | 3 | 50% |
| Manufacturing | 2 | 33% |
| Medical Device | 2 | 33% |
| Medical | 1 | 17% |
| Biotechnology | 1 | 17% |

9 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 2 | 33% |
| Series A | 1 | 17% |
| Series C | 1 | 17% |
| Series D | 1 | 17% |
| Funding Round | 1 | 17% |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Tianyu Semiconductor | Tianyu Semiconductor is a third-generation semiconductor silicon carbide epitaxial wafer manufacturer. |  |  | Feb 07, 2023 |  |
| Tianyu Semiconductor | Tianyu Semiconductor is a third-generation semiconductor silicon carbide epitaxial wafer manufacturer. | $176.7M | Series B | Feb 07, 2023 |  |
| Qinghai Lihao | Qinghai Lihao engages in the process technology research and development, production, sales and related supporting new energy business. | $306.5M | Series B | Sep 27, 2022 |  |
| Innoscience | Innoscience is an 8-inch Integrated Device Manufacturer (IDM) that focuses on GaN technology. The company was founded in 2015 and is headquartered in Zhuhai, Guangdong, China. | $410.3M | Series D | Feb 16, 2022 |  |
| Wego | Wego is a manufacturer of producing safe and affordable medical equipment. | $155M | Series A | Oct 29, 2021 |  |
| Immunochina | ImmunoChina Pharmaceuticals manufactures medical products. The Company produces cell injections, cell therapy drugs, and other products. ImmunoChina Pharmaceuticals also provides medical technology development, medical research, medical trial development, and other services. | $19.8M | Series C | Jan 22, 2019 |  |

6 of 6 investments shown.

## Co-investors
- [China Merchants Venture Capital](https://shizune.co/investors/profile/china-merchants-capital) — VC Fund, 2 deals together
- Guangdong Jiayuan Technology — VC Fund, 2 deals together
- [Guangdong Science and Technology Venture Capital](https://shizune.co/investors/profile/guangdong-science-and-technology-venture-capital) — VC Fund, 2 deals together
- Stem Capital — VC Fund, 2 deals together
- [CCB International](https://shizune.co/investors/profile/ccb-international) — VC Fund, 1 deal together
- [CDH Investments](https://shizune.co/investors/profile/cdh-investments) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does China-Belgium Direct Equity Investment Fund invest in?

China-Belgium Direct Equity Investment Fund invests primarily in Semiconductor, Manufacturing and Medical Device startups, most often at Series B and Series A stage. Most of the 6 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did China-Belgium Direct Equity Investment Fund last invest?

The most recent investment recorded for China-Belgium Direct Equity Investment Fund closed in Feb 2023. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co
